![]() O Safety: continued strong progress including good OCCY 6 growth and healthy acquisition contribution ![]() Strong cash performance continued balance sheet strength: cash conversion 9 of 96% (2022/23: 63%), above 90% target net debt/EBITDA 1.4 times, within operating range of up to 2 times.O Five acquisitions completed in financial year to date (three in first half) for £126m maximum total consideration healthy pipeline of potential acquisitions. O R&D investment up 5% to £52m, representing 5.5% of revenue Continued strategic investment to support future growth:.Return on Sales 4 of 18.7% (2022/23: 19.6%): principally reflecting higher net finance expense compares to strong performance, above pre-COVID level, in 2022/23 first half.Healthy contribution from recent acquisitions 7, adding over 5% to revenue and profit growth.O Adjusted 1 Profit before Taxation +3% OCCY 6 in line with first half of last year O Revenue +9% organic constant currency 6 (OCCY) revenue +5% Statutory Earnings before Interest and Taxation We remain on track to make further progress in the second half of the year." Marc Ronchetti, Group Chief Executive.Īdjusted 1 Earnings before Interest and Taxation (EBIT) These enabled us to deliver record revenue, profit and dividend, while further enhancing our growth opportunities through increased strategic investment, supported by a strong cash flow performance and continued balance sheet strength. The Group performance reflects the strength we derive from our Sustainable Growth Model and the long-term growth drivers that underpin our diverse portfolio. "Halma made good progress in the first half. Halma, the global group of life-saving technology companies focused on growing a safer, cleaner, healthier future for everyone, every day, today announces results for the 6 months to 30 September 2023. Record first half results and continued dividend growth
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |